s6y

BetterLife Pharma Inc.

Ticker
BETRF
CIK
1464165
Industry
Pharmaceutical Preparations
Formerly
Pivot Pharmaceuticals Inc., Neurokine Pharmaceuticals Inc.

Financials 58

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Jan 31, 2022
  2. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Jan 31, 2020
  3. 10-Q Quarterly Report for period ending Apr 30, 2019
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Apr 30, 2019
  5. 10-K Annual Report for period ending Jan 31, 2019
  6. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Jan 31, 2019
  7. 10-Q Quarterly Report for period ending Oct 31, 2018
  8. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Oct 31, 2018
  9. 10-Q Quarterly Report for period ending Jul 31, 2018
  10. 10-Q Quarterly Report for period ending Apr 30, 2018

All 58 financials filings

News 29

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K/A Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K/A Current report filing

All 29 news filings

Ownership 6

  1. 5 Annual statement of changes in beneficial ownership of securities
  2. 5 Annual statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities

Prospectus 4

  1. S-1/A General form of registration statement for all companies including face-amount certificate companies
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. S-1/A General form of registration statement for all companies including face-amount certificate companies
  4. S-1 General form of registration statement for all companies including face-amount certificate companies

Proxies 9

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEFR14A Definitive revised proxy soliciting materials
  6. DEFR14A Definitive revised proxy soliciting materials
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEF 14A Definitive proxy statements
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

Other 138

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. SCHEDULE 13G
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 138 other filings